User menu

Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.

Bibliographic reference Bosisio, Francesca M ; Wilmott, James S ; Volders, Nathalie ; Mercier, Marjorie ; Wouters, Jasper ; et. al. Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.. In: Modern Pathology, (2016)
Permanent URL http://hdl.handle.net/2078.1/172395
  1. Bastian Boris C., The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia, 10.1146/annurev-pathol-012513-104658
  2. Bae Jung Min, Choi Yoon Young, Kim Dae Suk, Lee Ji Hye, Jang Hong Sun, Lee Joo Hee, Kim Heesu, Oh Byung Ho, Roh Mi Ryung, Nam Kyoung Ae, Chung Kee Yang, Metastatic melanomas of unknown primary show better prognosis than those of known primary: A systematic review and meta-analysis of observational studies, 10.1016/j.jaad.2014.09.029
  3. Lo J. A., Fisher D. E., The melanoma revolution: From UV carcinogenesis to a new era in therapeutics, 10.1126/science.1253735
  4. Powles Thomas, Eder Joseph Paul, Fine Gregg D., Braiteh Fadi S., Loriot Yohann, Cruz Cristina, Bellmunt Joaquim, Burris Howard A., Petrylak Daniel P., Teng Siew-leng, Shen Xiaodong, Boyd Zachary, Hegde Priti S., Chen Daniel S., Vogelzang Nicholas J., MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer, 10.1038/nature13904
  5. Herbst Roy S., Soria Jean-Charles, Kowanetz Marcin, Fine Gregg D., Hamid Omid, Gordon Michael S., Sosman Jeffery A., McDermott David F., Powderly John D., Gettinger Scott N., Kohrt Holbrook E. K., Horn Leora, Lawrence Donald P., Rost Sandra, Leabman Maya, Xiao Yuanyuan, Mokatrin Ahmad, Koeppen Hartmut, Hegde Priti S., Mellman Ira, Chen Daniel S., Hodi F. Stephen, Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients, 10.1038/nature14011
  6. Tumeh Paul C., Harview Christina L., Yearley Jennifer H., Shintaku I. Peter, Taylor Emma J. M., Robert Lidia, Chmielowski Bartosz, Spasic Marko, Henry Gina, Ciobanu Voicu, West Alisha N., Carmona Manuel, Kivork Christine, Seja Elizabeth, Cherry Grace, Gutierrez Antonio J., Grogan Tristan R., Mateus Christine, Tomasic Gorana, Glaspy John A., Emerson Ryan O., Robins Harlan, Pierce Robert H., Elashoff David A., Robert Caroline, Ribas Antoni, PD-1 blockade induces responses by inhibiting adaptive immune resistance, 10.1038/nature13954
  7. Sharma Padmanee, Allison James P., Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential, 10.1016/j.cell.2015.03.030
  8. Zhou Dexi, Huang Cheng, Lin Zhen, Zhan Shuxiang, Kong Lingna, Fang Chengbo, Li Jun, Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways, 10.1016/j.cellsig.2013.11.004
  9. Martinez F. O., Gordon S., Locati M., Mantovani A., Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression, 10.4049/jimmunol.177.10.7303
  10. Biswas Subhra K, Mantovani Alberto, Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, 10.1038/ni.1937
  11. Zitvogel Laurence, Kroemer Guido, CD103+ Dendritic Cells Producing Interleukin-12 in Anticancer Immunosurveillance, 10.1016/j.ccell.2014.10.008
  12. Balkwill F. R., Capasso M., Hagemann T., The tumor microenvironment at a glance, 10.1242/jcs.116392
  13. Ladányi Andrea, Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma, 10.1111/pcmr.12371
  14. Kitamura Takanori, Qian Bin-Zhi, Pollard Jeffrey W., Immune cell promotion of metastasis, 10.1038/nri3789
  15. Smith Heath A., Kang Yibin, The metastasis-promoting roles of tumor-associated immune cells, 10.1007/s00109-013-1021-5
  16. Bulman Amanda, Neagu Monica, Constantin Carolina, Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring, 10.2174/1570164611310030003
  17. Clemente Claudio G., Mihm Martin C., Bufalino Rosaria, Zurrida Stefano, Collini Paola, Cascinelli Natale, Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma, 10.1002/(sici)1097-0142(19960401)77:7<1303::aid-cncr12>3.0.co;2-5
  18. Clark W. H., Elder D. E., Guerry D., Braitman L. E., Trock B. J., Schultz D., Synnestvedt M., Halpern A. C., Model Predicting Survival in Stage I Melanoma Based on Tumor Progression, 10.1093/jnci/81.24.1893
  19. Cipponi Arcadi, Wieers Grégoire, van Baren Nicolas, Coulie Pierre G., Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?, 10.1007/s00262-011-1026-2
  20. Hillen Femke, Baeten Coen I. M., van de Winkel Anouk, Creytens David, van der Schaft Daisy W. J., Winnepenninckx Véronique, Griffioen Arjan W., Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma, 10.1007/s00262-007-0353-9
  21. Hussein M R, Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions, 10.1136/jcp.2005.028860
  22. Fridman W.H., Remark R., Goc J., Giraldo N.A., Becht E., Hammond Scott A., Damotte D., Dieu-Nosjean M.-C., Sautès-Fridman Catherine, The Immune Microenvironment: A Major Player in Human Cancers, 10.1159/000362332
  23. Linnebacher Michael, Maletzki Claudia, Tumor-infiltrating B cells : The ignored players in tumor immunology, 10.4161/onci.20641
  24. Linnebacher Michael, Tumor-infiltrating B cells come into vogue, 10.3748/wjg.v19.i1.8
  25. Martinez-Rodriguez Miguel, Thompson Alec K, Monteagudo Carlos, A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma, 10.1111/his.12437
  26. Fremd Carlo, Schuetz Florian, Sohn Christof, Beckhove Philipp, Domschke Christoph, B cell-regulated immune responses in tumor models and cancer patients, 10.4161/onci.25443
  27. Ladányi Andrea, Kiss Judit, Mohos Anita, Somlai Beáta, Liszkay Gabriella, Gilde Katalin, Fejős Zsuzsanna, Gaudi István, Dobos Judit, Tímár József, Prognostic impact of B-cell density in cutaneous melanoma, 10.1007/s00262-011-1071-x
  28. Bruno Tullia C., French Jena D., Jordan Kimberly R., Ramirez Oscar, Sippel Trisha R., Borges Virginia F., Haugen Bryan R., McCarter Martin D., Waziri Allen, Slansky Jill E., Influence of human immune cells on cancer: studies at the University of Colorado, 10.1007/s12026-012-8346-y
  29. King D. Friday, Chronic atypical epithelial proliferation of Bowen : A historical and biographical note, 10.1097/00000372-198402000-00009
  30. Mascaro J M, Molgo M, Castel T, Castro J, Plasma Cells within the Infiltrate of Primary Cutaneous Malignant Melanoma of the Skin : A Confirmation of its Histoprognostic Value, 10.1097/00000372-198712000-00005
  31. Germain C, Front Immunol, 23, 6 (2015)
  32. Erdag G., Schaefer J. T., Smolkin M. E., Deacon D. H., Shea S. M., Dengel L. T., Patterson J. W., Slingluff C. L., Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma, 10.1158/0008-5472.can-11-3218
  33. Morton D, Surgery, 68, 158 (1970)
  34. Vale Andre M., Schroeder Harry W., Clinical consequences of defects in B-cell development, 10.1016/j.jaci.2010.02.018
  35. Karagiannis Panagiotis, Gilbert Amy E., Josephs Debra H., Ali Niwa, Dodev Tihomir, Saul Louise, Correa Isabel, Roberts Luke, Beddowes Emma, Koers Alexander, Hobbs Carl, Ferreira Silvia, Geh Jenny L.C., Healy Ciaran, Harries Mark, Acland Katharine M., Blower Philip J., Mitchell Tracey, Fear David J., Spicer James F., Lacy Katie E., Nestle Frank O., Karagiannis Sophia N., IgG4 subclass antibodies impair antitumor immunity in melanoma, 10.1172/jci65579
  36. O'neill P. A., Romsdahl M. M., IgA as a Blocking Factor in Human Malignant Melanoma, 10.3109/08820137409061123
  37. Doi Tomomitsu, Kanai Takanori, Mikami Yohei, Sujino Tomohisa, Jun Li, Ono Yuichi, Hayashi Atsushi, Hibi Toshifumi, IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestine, 10.1016/j.bbrc.2012.08.010
  38. Ningappa Mylarappa, Ashokkumar Chethan, Ranganathan Sarangarajan, Schmitt Lori, Higgs Brandon W., Sun Qing, Branca Maria, Mazariegos George, Zeevi Adriana, Abu-Elmagd Kareem, Squires Robert, Rudolph Jeffrey, Alissa Feras, Hakonarson Hakon, Sindhi Rakesh, Mucosal Plasma Cell Barrier Disruption During Intestine Transplant Rejection : , 10.1097/tp.0b013e3182708d9d
  39. Shalapour Shabnam, Font-Burgada Joan, Di Caro Giuseppe, Zhong Zhenyu, Sanchez-Lopez Elsa, Dhar Debanjan, Willimsky Gerald, Ammirante Massimo, Strasner Amy, Hansel Donna E., Jamieson Christina, Kane Christopher J., Klatte Tobias, Birner Peter, Kenner Lukas, Karin Michael, Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy, 10.1038/nature14395
  40. Egbuniwe Isioma U., Karagiannis Sophia N., Nestle Frank O., Lacy Katie E., Revisiting the role of B cells in skin immune surveillance, 10.1016/j.it.2014.12.006
  41. Dieu-Nosjean Marie-Caroline, Goc Jérémy, Giraldo Nicolas A., Sautès-Fridman Catherine, Fridman Wolf Herman, Tertiary lymphoid structures in cancer and beyond, 10.1016/j.it.2014.09.006
  42. Cipponi A., Mercier M., Seremet T., Baurain J.-F., Theate I., van den Oord J., Stas M., Boon T., Coulie P. G., van Baren N., Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases, 10.1158/0008-5472.can-12-1377
  43. Hahn Anika, Thiessen Nadja, Pabst Reinhard, Buettner Manuela, Bode Ulrike, Mesenteric lymph nodes are not required for an intestinal immunoglobulin A response to oral cholera toxin, 10.1111/j.1365-2567.2009.03197.x